Medicine and Health Sciences Commons^™

Oncolog, Volume 46, Number 11/12, November-December 2001, Karen Stuyck, Kerry L. Wright

OncoLog MD Anderson's Report to Physicians (All issues)

• Multidisciplinary Team Helps Patients with Cancer Overcome Cognitive Problems
• Protocols: Studies Focus on Cognitive Effects of Cancer and Its Treatment
• House Call: Simple Steps Can Put Patients on the Road to Well-Being
• Highly Selective Synthetic Binding Agents Target Different DNA Conformations

Oncolog, Volume 46, Number 10, October 2001, Dawn Chalaire, Kerry L. Wright, Mary K. Hughes Ms, Rn

OncoLog MD Anderson's Report to Physicians (All issues)

• Surgical Techniques, New Agents Target Breast Disease with Increasing Accuracy
• Undiagnosed Breast Clinic Provides Answers for Concerned Patients
• House Call: Tips for Coping with the Cosmetic Effects of Breast Cancer
• DiaLog: Breast Cancer and Body Image, by Mary K. Hughes, MS, RN, Department of Psychiatry
• New Screening and Diagnostic Techniques Are Changing the Practice of Breast Imaging

Oncolog, Volume 46, Number 09, September 2001, Beth Notzon, Kerry L. Wright, Renato Lenzi Md

OncoLog MD Anderson's Report to Physicians (All issues)

• Completing the Job: Multidisciplinary Effort Restores Form and Function, Improves Patients' Quality of Life
• House Call: Denial and Cancer
• Protocols: Studies Examine Treatments for Glioma
• DiaLog: Addressing the Problem of Patients' Denial, by Renato Lenzi, MD, Associate Professor, Department of Gastrointestinal Medical Oncology
• New Replication-Competent Adenovirus Shows Promise against Gliomas in Preclinical Studies

Oncolog, Volume 46, Number 05, May 2001, Kate O'Suilleabhain, Roy S. Herbst Md, Phd, Kerry L. Wright

OncoLog MD Anderson's Report to Physicians (All issues)

• Antiangiogenic Agents: Changing the Nature of Cancer Treatment
• DiaLog: Angiogenesis Research: Looking for New Ways to Measure Success, by Roy S. Herbst, MD, PhD, Assistant Professor, Department of Thoracic/Head and Neck Medical Oncology
• House Call: Overcome Fears of Cancer Recurrence by Taking Action
• Recognition Spurs Prevention of Osteoporosis in Patients with Cancer
• Protocols: Clinical Trials of Antiangiogenic Agents

Oncolog, Volume 46, Number 02, February 2001, Sunni Hosemann, Kerry L. Wright, Janet M. Bruner Md

OncoLog MD Anderson's Report to Physicians (All issues)

• Specialized Training and Techniques of Pathologists Lead to Targeted Therapies
• Protocols: Studies Examine High-Dose Chemotherapy for Breast Cancer
• High-Dose Chemotherapy for Breast Cancer: Completion of Clinical Trials Necessary
• DiaLog: Many Specialties, One Goal, by Janet M. Bruner, MD, Chairman, Department of Pathology
• House Call: Support Groups Offer Patients a Helping Hand
• Study Reveals Types of Diagnostic Errors and Their Costs

Department Of Radiation Oncology And Kimmel Cancer Center, Thomas Jefferson University, The Intronic G13964c Variant In P53 Is Not A High-Risk Mutation In Familial Breast Cancer In Australia., Anna Marsh, Amanda B Spurdle, Bruce C Turner, Sian Fereday, Heather Thorne, Gulietta M Pupo, Graham J Mann, John L Hopper, Joseph F Sambrook, Georgia Chenevix-Trench

Department of Radiation Oncology Faculty Papers

BACKGROUND: Mutations in BRCA1 and BRCA2 account for approximately 50% of breast cancer families with more than four affected cases, whereas exonic mutations in p53, PTEN, CHK2 and ATM may account for a very small proportion. It was recently reported that an intronic variant of p53--G13964C--occurred in three out of 42 (7.1%) 'hereditary' breast cancer patients, but not in any of 171 'sporadic' breast cancer control individuals (P = 0.0003). If this relatively frequent occurrence of G13964C in familial breast cancer and absence in control individuals were confirmed, then this would suggest that the G13964C variant plays a role in …